x

Coronavirus

UK Insists No Corners Cut in Approving Vaccine

LONDON — British regulators insisted that “no corners have been cut” during the assessment of the the COVID-19 vaccine developed by American drugmaker Pfizer and Germany’s BioNTech, which was cleared for emergency use on Wednesday.

In a briefing after the U.K.'s Medicines and Healthcare Products Regulatory Agency became the first regulator worldwide to approve the vaccine, its chair, Dr. June Raine, said the public can be “absolutely confident” that its standards are equivalent to those anywhere around the world.

Regulators also revealed the order by which the vaccine will be rolled out across the country over the coming weeks and months, beginning next week. The U.K. has ordered around 40 million doses of the vaccine, which can potentially immunize 20 million people as two doses are required.

Residents in nursing homes and their carers will be offered the vaccine first followed by those aged 80 and over and frontline health and social care workers. From there, the priority plan largely follows age groups.

According to Munir Pirmohamed, chair of a medicines panel, people will be immune seven days after the second dose.

RELATED

NEW YORK — New York City, which once had the nation’s strictest workplace vaccination rules for COVID-19, is ending one of its last such mandates, saying it will no longer require the shots for municipal employees including police officers, firefighters and teachers.

Top Stories

Columnists

A pregnant woman was driving in the HOV lane near Dallas.

General News

FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

Video

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. [email protected]

You may unsubscribe at any time using the link in our newsletter.